feed,title,long_url,short_url
Benzinga,41 Stocks Moving in Wednesday's Pre-Market Session,https://www.benzinga.com/news/20/12/18611690/41-stocks-moving-in-wednesdays-pre-market-session,https://j.mp/3qniqfm
Benzinga,"CareRx Signs New Multi-Year Contract with Seniors Home Operator, Adding 1,100 Beds",https://www.benzinga.com/pressreleases/20/12/n18611689/carerx-signs-new-multi-year-contract-with-seniors-home-operator-adding-1-100-beds,https://j.mp/3olX9Bf
Benzinga,RenovoRx Continues with Strong Momentum and Reaches Milestone of 100th Patient Enrolled in its Phase III TIGeR-PaC Clinical Trial,https://www.benzinga.com/pressreleases/20/12/n18611665/renovorx-continues-with-strong-momentum-and-reaches-milestone-of-100th-patient-enrolled-in-its-pha,https://j.mp/37rf16D
Benzinga,FibroGen to Present Safety and Efficacy Analyses from Roxadustat Global Phase 3 Program at American Society of Hematology Annual Meeting,https://www.benzinga.com/pressreleases/20/12/g18611606/fibrogen-to-present-safety-and-efficacy-analyses-from-roxadustat-global-phase-3-program-at-america,https://j.mp/3qkAbw1
Benzinga,Amicus Therapeutics Appoints Michael A. Kelly to its Board of Directors,https://www.benzinga.com/pressreleases/20/12/g18611604/amicus-therapeutics-appoints-michael-a-kelly-to-its-board-of-directors,https://j.mp/3odQcC2
Benzinga,Molecular Data Inc. Announces Changes of Chief Financial Officer,https://www.benzinga.com/pressreleases/20/12/g18611601/molecular-data-inc-announces-changes-of-chief-financial-officer,https://j.mp/3g2ePim
Benzinga,Medicenna Hosting Key Opinion Leader Call on MDNA55 for the Treatment of Recurrent Glioblastoma Multiforme,https://www.benzinga.com/pressreleases/20/12/g18611599/medicenna-hosting-key-opinion-leader-call-on-mdna55-for-the-treatment-of-recurrent-glioblastoma-mu,https://j.mp/3lw3PuL
